We Make Standards

Mission

  • Target Disease

    Diseases with high unmet medical demand and forming a global big market

  • Modality

    Decision for a modality that meets target delivery, versatility, and low toxicity

Features

  • Marketability

    Market potential of the pipeline and extensibility of possessed technologies

  • Speciality

    Practical expertise in the development process of biopharmaceuticals

  • Technology

    Possession of platform technologies for commercial production of new drugs

Our Science

  • Unmet medical needs

    Selection of target diseases considering unmet medical needs and market size

  • Tumor Microenvironment

    Targeted immunotherapies for the tumor microenvironment

  • Exosome

    Exosomes as an efficient drug modality

We make standards We make standards We make standards We make standards We make standards

Story

Newsroom